Detalhe da pesquisa
1.
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Respir Res
; 24(1): 6, 2023 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624431
2.
Inorganic pyrophosphate is reduced in patients with systemic sclerosis.
Rheumatology (Oxford)
; 61(3): 1158-1165, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152415
3.
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.
Rheumatology (Oxford)
; 61(10): 4035-4046, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238334
4.
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.
Ann Rheum Dis
; 78(7): 979-987, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30967395
5.
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Arthritis Rheum
; 65(11): 2737-47, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24122180
6.
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Ann Rheum Dis
; 72(11): 1747-55, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24092682
7.
Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire.
Rheum Dis Clin North Am
; 49(2): 463-481, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028847
8.
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis
; 70(1): 32-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20805294
9.
Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung study.
Clin Trials
; 7(1): 85-9, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20032002
10.
Safety and effectiveness of abatacept in systemic sclerosis: The EUSTAR experience.
Semin Arthritis Rheum
; 50(6): 1489-1493, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165035
11.
Cyclophosphamide versus placebo in scleroderma lung disease.
N Engl J Med
; 354(25): 2655-66, 2006 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-16790698
12.
Echocardiogram: The GPS to GPA's Heart (Granulomatosis with Polyangiitis).
Case Rep Rheumatol
; 2019: 7609386, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30800485
13.
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry.
J Rheumatol
; 46(2): 176-183, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30275260
14.
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
Am J Respir Crit Care Med
; 176(10): 1026-34, 2007 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17717203
15.
Pomalidomide in Patients with Interstitial Lung Disease due to Systemic Sclerosis: A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study.
J Rheumatol
; 45(3): 405-410, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29093152
16.
P-wave amplitude and pulmonary artery pressure in scleroderma.
J Electrocardiol
; 39(4): 385-8, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16919671
17.
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Lancet Respir Med
; 4(9): 708-719, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27469583
18.
Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Semin Arthritis Rheum
; 45(3): 309-14, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26210782
19.
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.
Semin Arthritis Rheum
; 44(1): 55-62, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24709277
20.
Inclusion body myositis in a patient with RNA polymerase III antibody-positive systemic sclerosis.
J Rheumatol
; 42(4): 730-2, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25834244